COVID-19 and Myositis: What We Know So Far

PURPOSE: Myositis as a rare manifestation of COVID-19 is only recently being reported. This review examines the current literature on COVID-19-induced myositis focusing on etiopathogenesis, clinical presentations, diagnostic practices, and therapeutic challenges with immunosuppression, and the diffi...

Descripción completa

Detalles Bibliográficos
Autores principales: Saud, Ahmad, Naveen, R, Aggarwal, Rohit, Gupta, Latika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Inflammatory Muscle Disease (L Diederichsen and H Chinoy, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254439/
https://www.ncbi.nlm.nih.gov/pubmed/34216297
http://dx.doi.org/10.1007/s11926-021-01023-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254439/
https://www.ncbi.nlm.nih.gov/pubmed/34216297
http://dx.doi.org/10.1007/s11926-021-01023-9

Ejemplares similares